Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Dec 2, 2022
  • 3 Class I recalls
  • Last warning letter 2022
Inspections 2 0 OAI
Recalls 89 3 Class I (3%)
Warning letters 1 Latest Oct 21, 2022
510(k) clearances 3 Latest Feb 9, 2023

Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center has 89 FDA recalls (3 Class I), 2 inspections, 3 510(k) clearances and 0 compliance actions on record. FDA has issued 1 warning letter to Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center, the most recent on Oct 21, 2022. FDA has published 7 Form 483s for Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center.

What these totals cover: FDA records filed under the name "Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center" and its spelling variants "Nephron Sterile Compounding Center", "Nephron Pharmaceuticals", "Nephron Pharmaceuticals Corporation".

Latest recall
D-0257-2025 · Class II · Feb 10, 2025
Latest inspection
Dec 2, 2022 · VAI
Latest 510(k)
Feb 9, 2023

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls89 (3 Class I)Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances3Nov 15, 2026File dated Nov 9, 2026Current
Inspections2Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 6 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 1 inspection (0 OAI), 0 warning letters, 63 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 9 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500010
202400000
202300090
2022100630
202100000
202000000
201900060
201800000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center FDA Warning Letters

1 warning letter on Oct 21, 2022.

IssuedSubjectIssuing officeClose-out letter
Oct 21, 2022 · Letter on fda.gov Compounding Pharmacy/Adulterated Drug ProductsOffice of Pharmaceutical Quality Operations, Division II

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center Form 483s

7 Form 483s published by FDA.

DateDocumentFEI
Sep 25, 2024 · Document on fda.gov 4833011158388
Feb 10, 2023 · Document on fda.gov 4833011158388
Dec 2, 2022 · Document on fda.gov 4833010247115
Apr 20, 2022 · Document on fda.gov 4833011158388
Nov 15, 2019 · Document on fda.gov 4833011158388
May 30, 2018 · Document on fda.gov 4833011158388
May 15, 2017 · Document on fda.gov 4833011158388

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent recalls

89 recall records from Jun 22, 2011 to Feb 10, 2025. Showing the 20 most recent. View all 89 recall records

NumberClassProductDate
D-0257-2025Class IISodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourcing…Feb 10, 2025
D-0359-2023Class IIPhenylephrine HCl Injection, USP, 1 mg/10 mL (100 mcg/mL), 10 mL Single-Dose Vial, packaged in 30 x…Feb 22, 2023
D-0362-2023Class IIPhenylephrine HCl in 0.9% Sodium Chloride Injection, USP, 50 mg/250 mL (200 mcg/mL), 250 mL…Feb 22, 2023
D-0357-2023Class IINorepinephrine Bitartrate in 0.9% Sodium Chloride Injection, USP, 4 mg/250 mL (16 mcg/mL*), 250 mL…Feb 22, 2023
D-0361-2023Class IIPhenylephrine HCl Injection, USP, 0.8 mg/10 mL (80 mcg/mL), 10 mL Single-Dose Vial, packaged in 30 x…Feb 22, 2023
D-0356-2023Class IINorepinephrine Bitartrate in 0.9% Sodium Chloride Injection, USP, 8 mg/250 mL (32 mcg/mL*), 250 mL…Feb 22, 2023
D-0355-2023Class IIDiltiazem HCl in 0.7% Sodium Chloride Injection, 125 mg/125 mL (1 mg/mL), 125 mL Single-Dose…Feb 22, 2023
D-0360-2023Class IIPhenylephrine HCl Injection, USP, 0.4 mg/10 mL (40 mcg/mL), 10 mL Single-Dose Vial, packaged in 30 x…Feb 22, 2023
D-0358-2023Class IINorepinephrine Bitartrate in 0.9% Sodium Chloride Injection, USP, 16 mg/250 mL (64 mcg/mL*), 250 mL…Feb 22, 2023
D-0099-2023Class IIRocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL), 5 x 5 mL Pre-Filled Syringe, 6 x 5 syringe…Jan 6, 2023
D-0065-2023Class IIPF-Neostigmine Methylsulfate Injection, USP 3 mg/3 mL (1 mg/mL) vial, Rx Only, Nephron 503B…Nov 10, 2022
D-0064-2023Class IIPF-Labetalol HCl Injection, USP 20 mg/4 mL (5 mg/mL) vial, Rx Only, Nephron 503B Outsourcing…Nov 10, 2022
D-1344-2022Class IIPF-Neostigmine Methylsulfate Injection, USP, 3 mg/3 mL (1 mg/mL), One 3 mL Unit-Dose Vial, packaged…Aug 10, 2022
D-1347-2022Class IIPF-Labetalol HCl Injection, USP, 20 mg/4 mL (5 mg/mL), One 4 mL Unit-Dose Vial, packaged in 30 x 4…Aug 10, 2022
D-1345-2022Class IITrisodium Citrate 0.5% Solution, (0.5%/4L), contains Per Liter: Sodium 140 mmol/L, Chloride 86…Aug 10, 2022
D-1346-2022Class IIPF-0.125% Bupivacaine HCl Injection, USP, 625 mg/500 mL (1.25 mg/mL), 500 mL bag, packaged in 10 x 1…Aug 10, 2022
D-1256-2022Class IIHYDROmorphone HCl Injection, USP, 6 mg/30 mL (0.2 mg/mL) syringes, 5 x 30 mL Pre-Filled Syringes per…Jun 30, 2022
D-1258-2022Class IIHYDROmorphone HCl Injection, USP, 50 mg/50 mL (1 mg/mL) syringes, packaged in 5 x 50 mL Pre-Filled…Jun 30, 2022
D-1277-2022Class IIRocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL) syringe, packaged in 5 x 5 mL Pre-Filled…Jun 30, 2022
D-1268-2022Class IIMorphine Sulfate Injection, USP, 1 mg/mL syringe, packaged in 5 x 1 mL Pre-Filled Syringes per…Jun 30, 2022

Recent FDA inspections

2 inspections from Nov 4, 2008 to Dec 2, 2022.

DateSiteProductClassificationFEI
Dec 2, 2022Murray, KYDrugsVoluntary Action Indicated (VAI)3010247115
Nov 4, 2008Mountain Home, IDDrugsNo Action Indicated (NAI)3004462991
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

2 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3010247115Murray, KY1Dec 2, 2022
FEI 3004462991Mountain Home, ID1Nov 4, 2008

Recent 510(k) clearances

3 510(k) clearances from Apr 20, 2012 to Feb 9, 2023.

K-NumberDeviceDate
K223559Nephron Nitrile Powder-Free Nitrile Examination Gloves (Tested For Use With Chemotherapy Drugs)Feb 9, 2023
K113033SODIUM CHLORDE INHALATION SOLUTION, 0.9% USP-3MLJun 19, 2012
K120051SODIUM CHLORIDE INHALATION SOLUTION, 3%, 7%, AND 10%, USP-4MLApr 20, 2012

Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center and the FDA: common questions

Has Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center. The most recent is dated Oct 21, 2022, with the subject "Compounding Pharmacy/Adulterated Drug Products".

Has Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center received an FDA Form 483?

FDA has published 7 Form 483s for Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center in its reading room, the most recent dated Sep 25, 2024. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center?

The most recent FDA inspection on file ended Dec 2, 2022 at Murray, KY and was classified VAI. FDA has 2 inspections of Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center on file.

Has Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center had an FDA recall?

Yes. Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center has 89 FDA recalls on record, 3 of them Class I, the most serious class. The most recent started Feb 10, 2025.

Need more than this page shows? Ask about Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.